Palantir CEO Karp twice slams short sellers as stock suffers worst week since April
Palantir CEO Alex Karp twice confronted short sellers this week as the company’s shares suffered a double-digit drop.
Millions more Americans could access obesity drugs after Trump’s deals with Eli Lilly, Novo Nordisk
Medicare will start covering obesity drugs for the first time, which could open access to millions of seniors and spur more private insurers to follow suit.
Fed’s Miran says stablecoin surge could help push interest rates lower
The central banker said the Fed might need to lower its own policy rate to avoid unintentionally slowing the economy.
Democratic leader offers deal to reopen government but Republicans sneer
The U.S. government shutdown has dragged on for 38 days because of a dispute over whether ACA tax credits should be included in a stop-gap funding bill.
Trump pardons New York baseball star Darryl Strawberry for tax evasion conviction
President Donald Trump has pardoned multiple high-profile figures since returning to the White House, including Binance founder Changpeng Zhao.
Markets could face a digestion period next week as earnings, data slow to a trickle
This week’s choppiness could carry into the week ahead in the absence of any major catalysts on the calendar.
Time to snap up Oracle, now down more than 30% in past two months, says Carter Worth
What the charts are saying about Oracle, according to Carter Worth.
Altimeter’s Brad Gerstner says market pullback is healthy, sees no bubble in tech
Gerstner pushed back on the idea that the market is in bubble territory.
Stocks making the biggest moves midday: Block, Archer Aviation, Akamai, Globus Medical and more
These are some of the stocks posting the largest moves midday.
An analyst worries OpenAI will miss its ‘extravagant’ spending commitments. These stocks would be the most vulnerable
D.A. Davidson analyst Gil Luria pointed to a handful of AI stocks at risk if OpenAI proves incapable of following through on its deals.